- Categorical baseline clinical and demographic characteristics.
| Variables | Development of NOAF | 95% CI | |||||
|---|---|---|---|---|---|---|---|
| n (%) | Yes | Total | P-value | OR | Lower | Upper | |
| Age at visit (binned) | |||||||
| 56+ | 146 (56.4) | 19 (86.4) | 165 (58.7) | 0.01 | 5.756 | 1.507 | 21.99 |
| Gender | |||||||
| Male | 213 (82.2) | 19 (86.4) | 232 (82.6) | 0.45 | 1.687 | 0.431 | 6.601 |
| Body mass index | |||||||
| >30 | 80 (30.9) | 7 (31.8) | 87 (31.0) | 0.46 | 0.684 | 0.251 | 1.867 |
| Smoking status | |||||||
| Smoker | 98 (37.8) | 8 (36.4) | 106 (37.7) | 0.75 | 1.169 | 0.444 | 3.079 |
| Hypertension | |||||||
| Yes | 144 (55.6) | 16 (72.7) | 160 (56.9) | 0.218 | 1.983 | 0.667 | 5.89 |
| Diabetes | |||||||
| Yes | 163 (62.9) | 13 (59.1) | 176 (62.6) | 0.059 | 0.346 | 0.115 | 1.042 |
| Type of MI | |||||||
| STEMI | 163 (62.9) | 10 (45.5) | 173 (61.6) | 0.23 | 0.575 | 0.231 | 1.430 |
| NSTEMI | 96 (37.1) | 12 (54.5) | 108 (38.4) | ||||
| Presentation timing | |||||||
| Late | 57 (22.0) | 5 (22.7) | 62 (22.1) | 0.72 | 1.220 | 0.410 | 3.635 |
| Presenting heart rate | |||||||
| >100 | 45 (17.4) | 3 (13.6) | 48 (17.1) | 0.78 | 1.208 | 0.320 | 4.563 |
| Follow-up outcome and complications | |||||||
| Developed complications | 104 (40.2) | 11 (50.0) | 115 (40.9) | 0.40 | 0.673 | 0.267 | 1.695 |
| Mortality | |||||||
| Died during hospitalizing or follow-up | 17 (6.6) | 5 (22.7) | 22 (7.8) | 0.031 | 4.629 | 1.152 | 18.593 |
Values are presented as number and percentage (%). OR: odds ratio, CI: confidence interval, NOAF: new-onset atrial fibrillation, MI: myocardial infarction, STEMI: ST elevation myocardial infarction, NSTEMI: non-ST elevation myocardial infarction